Page 5 - rcv31n3.vp

PUBLICACIÓN OFICIAL DE LA SOCIEDAD URUGUAYA DE CARDIOLOGÍA

Volume 31 - Number 3 - December 2016
Lista de Editorials
avisadores Decisions time at the Uruguayan Journal of Cardiology
Walter Reyes Caorsi·················································· 371
2016, a positive evaluation
ANTIAMOLL Andrea Simeone ··················································· 374
Opinion article
Bicentennial of a symbol: the stethoscope. Birth and agony of physical examination
ASTRAZENECA Baltasar Aguilar Fleitas················································ 375
Artículos originales
Usefulness of the SAMe-TT2R2 score in the control of oral anticoagulation with warfarin in patients
with non-valvular atrial fibrillation
BAYER Andreina Gómez, Stephania Peixoto, María Azcúnaga, Natalia Lluberas, Gabriela Silvera,
Pablo Álvarez, Gabriela Ormaechea, Ricardo Lluberas ····························· 381
Pharmacologic stress echocardiography as a prognostic tool in patients
BOEHRINGER with known or suspected coronary artery disease
INGELHEIM Alejandra Musacco, Natalia Moreira, José Pérez Arrarte, Roberto Ricca-Mallada,
Enrique Domínguez, Sergio Giovanetti, Horacio Vázquez Nosiglia ······················ 390
Prescription of statins, adherence and lipid levels two years
CELSIUS after hospitalization for coronary disease
Gerard Burdiat, Horacio Vázquez Nosiglia, Edgardo Sandoya, Carlos Olalde, Jorge Tejada ········ 398
Controversies in cardiology
What should be the target blood pressure, 140/90 mmHg or 120/80 mmHg?
CONAPROLE Target blood pressure should be 120/80 mmHg
Óscar Bazzino····················································· 405
Target blood pressure should be 140/90 mmHg
GADOR Edgardo Sandoya··················································· 408
Review article
The best of the 2016 Congress of the European Society of Cardiology
LAZAR Agustina Bonino, Florencia Cristar, Florencia Di Landro····························· 414
Editorial comments
ACC and AHA update guidelines on the duration of double antiplatelet therapy
NOAS in patients with coronary artery disease
Óscar Bazzino ····················································· 420
Guidelines yes, tracts no. Comments on the updates of the ESC and AHA / ACC guidelines for the
OMROM diagnosis and management of heart failure
Pablo Álvarez Rocha ················································· 427
Cardiologists in Training Committee section
Positive ergometric test in asymptomatic patient. Topic review from an infrequent case
PHILIPS Sebastián Lorenzo ·················································· 435
Selected articles
European Heart Journal
ROEMMERS The year in cardiology 2015: imaging
Oliver Gaemperli, Victoria Delgado, Gilbert Habib, Philipp A. Kaufmann, Jeroen J. Bax ·········· 440
The year in cardiology 2015: arrhythmias and device therapy
SAINT JUDE Jan Steffel, Pierre Jais, Gerhard Hindricks····································· 452
MEDICAL Heart
Almanac 2015: Atrial fibrillation research in Heart
Muhammad Jawad-Ul-Qamar, Paulus Kirchhof·································· 461
SERVIMEDIC
Special diabetes (I)
Prologue
TEVA Washington Vignolo, Bernardo Layerle ······································ 475
Cardiovascular prevention in the diabetic patient
Washington Vignolo, Bernardo Layerle ······································ 477
TRESUL Diabetes and cardiovascular disease in Uruguay
Edgardo Sandoya··················································· 505
Autonomic cardiovascular neuropathy in diabetes
José Aníbal Manfredi Carabetti ··········································· 515
URUFARMA
Update on antidiabetic drugs and cardiovascular risk
María del Pilar Serra Sansone ············································ 522